In silico Study on Inhibition of NS5 Protein of Dengue Virus
DOI:
https://doi.org/10.37591/(rrjobi).v4i2.9Abstract
Abstract
Dengue fever is a flu-like illness. It is caused by a virus. The infection is passed to humans through mosquito bites. Statistical survey has revealed that every year 5,00,000 people get hospitalized due to dengue. Therefore there arises a serious necessity to find a drug molecule to cure this disease. At the first, we identified the proteins involved in the disease for which we obtained FASTA sequence using NCBI. Sequence alignment of the proteins was carried out by using BLAST (Basic Local Alignment Search Tool), this tool compares the query sequence with the sequences in database. For each comparison, it gives the E- value, identity, and score. Out of these parameters, we focus on 2 parameters - Identity, to be more than 85% and E- value to be -100. Those sequences which satisfy the required values of E-value and Identity are selected for analysis of structure by SWISS MODEL. Identification of the ligand was done by using RCSB database and the sequence obtained from NCBI was used to find PDB files for corresponding proteins by finding out there PDB id’s. Using these PDB id’s ligands where obtained from ‘ligand expo’ in SDF format and these SDF files were converted to PDB and these were further used for docking, by this two ligands were found out to be the most suitable lead molecules-7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-(2'-O-METHYL)-GUANOSINE and B-OCTYLGLUCOSIDE were found to have binding energy of -123.2 and -84.61 respectively for envelope protein and NS5 protein.
Keywords:Dengue fever, FASTA, BLAST, SWISS MODEL
Cite this Article
Shubham Raikar, Neha Patil, Madhusudhan Kulkarni et al. In silico study on Inhibition of NS5 Protein of Dengue Virus. Research & Reviews: A Journal of Bioinformatics. 2017; 4(2): 28–43p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |